Clinical trials
Hematologic Neoplasms trials in the Netherlands
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
43 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2006 | 2 |
| 2007 | 2 |
| 2008 | 1 |
| 2009 | 3 |
| 2012 | 2 |
| 2013 | 4 |
| 2014 | 2 |
| 2016 | 4 |
| 2017 | 4 |
| 2018 | 3 |
| 2019 | 1 |
| 2020 | 4 |
| 2021 | 4 |
| 2022 | 1 |
| 2024 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 19 |
| Recruiting | 7 |
| Active, not recruiting | 6 |
| Terminated | 5 |
| Unknown status | 4 |
| Enrolling by invitation | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Janssen Research & Development, LLC | 4 |
| Novartis Pharmaceuticals | 4 |
| Kiadis Pharma | 3 |
| Maastricht University Medical Center | 3 |
| Gamida Cell ltd | 2 |
| Janssen-Cilag B.V. | 2 |
| AbbVie | 1 |
| Amgen | 1 |
| Amsterdam UMC, location VUmc | 1 |
| AstraZeneca | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hematologic Neoplasms | 43 |
| Leukemia, Myeloid, Acute | 11 |
| Neoplasms | 8 |
| Myelodysplastic Syndromes | 7 |
| Multiple Myeloma | 6 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 6 |
| Leukemia | 4 |
| Graft vs Host Disease | 3 |
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 3 |
| Leukemia, Myeloid | 3 |
Trials
Showing 26 to 43 of 43. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.